Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors

September 19, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search